Found: 41
Select item for more details and to access through your institution.
SEOM guideline for the treatment of malignant glioma.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 7, p. 545, doi. 10.1007/s12094-012-0839-6
- By:
- Publication type:
- Article
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 9, p. 677, doi. 10.1007/s12094-011-0714-x
- By:
- Publication type:
- Article
Update on the diagnosis of cancer of unknown primary (CUP) origin.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 7, p. 434, doi. 10.1007/s12094-011-0679-9
- By:
- Publication type:
- Article
Approval denied by the European Medicines Agency (EMA) for bevacizumab in the treatment of high-grade glioma recurrence: a good idea or a grave error?
- Published in:
- 2011
- By:
- Publication type:
- Letter
Hypoxia: The Cornerstone of Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 22, p. 12608, doi. 10.3390/ijms222212608
- By:
- Publication type:
- Article
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.
- Published in:
- Neuroradiology, 2023, v. 65, n. 9, p. 1343, doi. 10.1007/s00234-023-03196-9
- By:
- Publication type:
- Article
Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 349, doi. 10.1093/nop/npac054
- By:
- Publication type:
- Article
Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab.
- Published in:
- Neuro-Oncology Practice, 2017, v. 4, n. 1, p. 15, doi. 10.1093/nop/npw004
- By:
- Publication type:
- Article
Genotyping low-grade gliomas among Hispanics.
- Published in:
- Neuro-Oncology Practice, 2016, v. 3, n. 3, p. 164, doi. 10.1093/nop/npv061
- By:
- Publication type:
- Article
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18608-8
- By:
- Publication type:
- Article
Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.865171
- By:
- Publication type:
- Article
Prospective pilot study to explore the melatonin level in brain tumor patients undergoing radiotherapy.
- Published in:
- Sleep & Breathing, 2022, v. 26, n. 1, p. 469, doi. 10.1007/s11325-021-02365-5
- By:
- Publication type:
- Article
Neuropatía inducida por el tratamiento médico del cáncer.
- Published in:
- Médicas UIS, 2010, v. 23, n. 2, p. 100
- By:
- Publication type:
- Article
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 735, doi. 10.3390/cancers16040735
- By:
- Publication type:
- Article
Unlocking Bevacizumab's Potential: rCBV max as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 161, doi. 10.3390/cancers16010161
- By:
- Publication type:
- Article
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5420, doi. 10.3390/cancers13215420
- By:
- Publication type:
- Article
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 729, doi. 10.1007/s10637-010-9561-9
- By:
- Publication type:
- Article
Mitomycin-C and Vinblastine in Advanced Breast Cancer.
- Published in:
- Oncology, 1989, v. 46, n. 3, p. 137, doi. 10.1159/000226702
- By:
- Publication type:
- Article
Pseudoprogression as an adverse event of glioblastoma therapy.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2858, doi. 10.1002/cam4.1242
- By:
- Publication type:
- Article
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47642-2
- By:
- Publication type:
- Article
Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1616, doi. 10.1093/neuonc/noab125
- By:
- Publication type:
- Article
Reply to: "Extended adjuvant temozolomide in newly diagnosed glioblastoma: is more less?".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1889, doi. 10.1093/neuonc/noaa209
- By:
- Publication type:
- Article
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1851, doi. 10.1093/neuonc/noaa107
- By:
- Publication type:
- Article
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 886, doi. 10.1093/neuonc/noaa045
- By:
- Publication type:
- Article
Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
- By:
- Publication type:
- Article
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1498
- By:
- Publication type:
- Article
Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 1, p. 130, doi. 10.1159/000505684
- By:
- Publication type:
- Article
A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170632
- By:
- Publication type:
- Article
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161484
- By:
- Publication type:
- Article
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3529, doi. 10.3390/cells10123529
- By:
- Publication type:
- Article
Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 4, p. 321, doi. 10.1007/s11523-014-0305-1
- By:
- Publication type:
- Article
Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 2, p. 367, doi. 10.1007/s11060-017-2726-z
- By:
- Publication type:
- Article
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 363, doi. 10.1007/s11060-017-2660-0
- By:
- Publication type:
- Article
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 569, doi. 10.1007/s11060-016-2065-5
- By:
- Publication type:
- Article
Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 117, n. 1, p. 77, doi. 10.1007/s11060-013-1352-7
- By:
- Publication type:
- Article
Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 109, n. 1, p. 137, doi. 10.1007/s11060-012-0879-3
- By:
- Publication type:
- Article
Salvage surgical resection after high‐dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias—A study of the Spanish Group for Research on Sarcomas (GEIS)Presented in part at the Thirty‐Eighth Annual Meeting of the American Society of Clinical Oncology, Orlando, May 18–21, 2002.
- Published in:
- Journal of Surgical Oncology, 2004, v. 88, n. 1, p. 44, doi. 10.1002/jso.20131
- By:
- Publication type:
- Article
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 5, p. 755, doi. 10.1093/neuonc/noab243
- By:
- Publication type:
- Article
Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
- Published in:
- PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0217340
- By:
- Publication type:
- Article
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects.
- Published in:
- OncoTargets & Therapy, 2023, v. 16, p. 71, doi. 10.2147/OTT.S366371
- By:
- Publication type:
- Article